Journal article icon

Journal article

The best of times, the worst of times for psychiatric disease.

Abstract:
As long-awaited advances in psychiatric genetics begin to materialize in force, promising to steer us safely to the best of times in psychiatric disease research, many pharmaceutical companies pull away from the challenge of drug development, threatening to bring us to the worst of times for the field. There is a real danger of missed opportunities and a sense of urgency for defining a clear path forward. © 2012 Nature America, Inc. All rights reserved.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1038/nn.3115

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Human Genetics Wt Centre
Role:
Author


Journal:
Nature neuroscience More from this journal
Volume:
15
Issue:
6
Pages:
811-812
Publication date:
2012-06-01
DOI:
EISSN:
1546-1726
ISSN:
1097-6256


Language:
English
Keywords:
Pubs id:
pubs:335146
UUID:
uuid:f348ea6a-0ecc-4024-b526-c956653674f6
Local pid:
pubs:335146
Source identifiers:
335146
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP